Innovations in Dermatology: Virtual Fall Conference 2021  

SEPTEMBER 17 – 20


AGENDA

ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers
in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

*All sessions listed in Eastern time.

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Clinical trial data on the efficacy and safety of established and emerging agents for the treatment of skin disorders in pediatric patients
  • Greater competence related to:
    • Identifying skin disorders in pediatric patients

 

 

 

 

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Clinical trial data on the efficacy, safety, and tolerability of novel therapies for dermatologic conditions in women 
    • Psychosocial impact of dermatologic conditions in women
  • Greater competence related to:
    • Identifying women with dermatologic conditions who are most likely to benefit from new and emerging treatment options

 

 

 

 

 

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding:
    • Clinical data on new/emerging topical AD medications
    • Clinical effect of investigational targeted systemic/biologic agents for AD
  • Greater competence related to:
    • Integrating into practice treatments that target the inflammatory etiology of AD
    • Selecting age-appropriate treatment based on AD severity
    • Tailoring evidence-based AD therapies based on patient characteristics

 

 

 

 

 

LEARNING OBJECTIVES

Upon completion of this activity, participants will have:

  • Increased knowledge regarding the:
    • Targeted treatments for psoriasis in the context of disease pathophysiology
    • Integration of new/emerging topical psoriasis treatments in care plans across the severity spectrum
    • Data on risks and benefits for systemic/biologic psoriasis treatments
  • Greater competence related to:
    • Incorporating biologic agents as part of a treat-to-treat strategy
    • Implementing evidence-based treatments for moderate to severe psoriasis
    • Selecting psoriasis treatments based on patient characteristics and prior treatment history
  • Greater confidence in their ability to:
    • Tailor psoriasis treatments based on patient preference and presentation

 

 

 

 

 

LEARNING OBJECTIVES

Upon completion of this activity, participants will be better able to:

  • Summarize clinical data supporting new/emerging acne treatments
  • Develop individualized management strategies for acne that consider new, emerging, and nonprescription treatments
  • Interpret clinical data supporting new/emerging treatments for rosacea in the context of specific treatment goals
  • Summarize the benefits and limitations of neurotoxin and filler treatment options for aesthetic dermatology of the face
  • Describe strategies that mitigate and minimize the risk for complications from fillers and neuromodulators